Research reveals COVID-19’s lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

Michigan Lawmakers Urge Congress to Consider Psychedelics

Oregon, Colorado and California aren’t the only states breaking the taboo against psychedelics by embracing the long-demonized class of drugs for mental healthcare. Michigan is

September 13, 2023

Cancer drug holds promise for shrinking polycystic kidney cysts

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.

January 22, 2024

New Alzheimer’s guidelines provide comprehensive framework for diagnosis

We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer’s disease (AD) and AD-related neurodegenerative disorders (ADRD) that are rapidly

December 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.